{
  "folder": "IC-223",
  "content": "{{knowledge objective\n|Identifiant=OIC-223-04-A\n|Item_parent=Dyslipidemia\n|Item_parent_short=Dyslipidemia\n|Rank=A\n|Title=When to test for dyslipidaemia?\n|Description=None\n|Rubric=Testing\n|Contributors=Laurence Duvillard, Bruno Verg\u00e8s, Benjamin Bouillet, Laurence Amar, Christian Boissier, Tristan Mirault, Claire Le Hello\n|Order=4}}\nMandatory screening :\n\n*In cases of secondary prevention (history of cardiovascular accident or asymptomatic atherosclerosis authenticated on imaging).\n*In the case of cardiovascular risk factors (family history of early-onset coronary disease, smoking, high blood pressure, diabetes, chronic renal failure).\n*If you are prescribed drugs likely to alter lipid metabolism (corticosteroids, oestroprogestins, retinoids, antiretrovirals, neuroleptics, mTOR inhibitors, etc.).\n\nScreening recommended in the absence of any cardiovascular risk factor\n\n*from the age of 40 in men\n*from the age of 50 in women and all post-menopausal women\n*in all women when taking hormonal contraception.",
  "question": {
    "question": "When should screening for dyslipidaemia be mandatory?",
    "option_a": "In all individuals over the age of 30",
    "option_b": "In cases of secondary prevention or cardiovascular risk factors",
    "option_c": "In individuals who are prescribed any medication",
    "option_d": "In all women over the age of 45",
    "correct_option": "B"
  }
}